Literature DB >> 9447840

Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations.

A W Langerak1, T Szczepański, M van der Burg, I L Wolvers-Tettero, J J van Dongen.   

Abstract

Molecular analysis of T cell receptor (TCR) genes is frequently used to prove or exclude clonality and thereby support the diagnosis of suspect T cell proliferations. PCR techniques are more and more being used for molecular clonality studies. The main disadvantage of the PCR-based detection of clonal TCR gene rearrangements, is the risk of false-positive results due to 'background' amplification of similar rearrangements in polyclonal reactive T lymphocytes. Therefore, PCR-based clonality assessment should include analyses that discern between PCR products derived from monoclonal and polyclonal cell populations. One such method is heteroduplex analysis, in which homo- and heteroduplexes resulting from denaturation (at 94 degrees C) and renaturation (at lower temperatures) of PCR products, are separated in non-denaturing polyacrylamide gels based on their conformation. After denaturation/renaturation, PCR products of clonally rearranged TCR genes give rise to homoduplexes, whereas in case of polyclonal cells heteroduplexes with heterogeneous junctions are formed. We studied heteroduplex PCR analysis of TCR gene rearrangements with respect to the time and temperature of renaturation and the size of the PCR products. Variation in time did not have much influence, but higher renaturation temperatures (>30 degrees C) clearly showed better duplex formation. Nevertheless, distinction between monoclonal and polyclonal samples was found to be more reliable at a renaturation temperature of 4 degrees C, using relatively short PCR products. To determine the sensitivity of heteroduplex analysis with renaturation at 4 degrees C, (c)DNA of T cell malignancies with proven clonal rearrangements was serially diluted in (c)DNA of polyclonal mononuclear peripheral blood cells and amplified using V and C primers (TCRB genes) or V and J primers (TCRG and TCRD genes). Clonal TCRB and TCRD gene rearrangements could be detected with a sensitivity of at least 5%, whereas the sensitivity for TCRG genes was somewhat lower (10-15%). The latter could be improved by use of Vgamma member primers instead of Vgamma family primers. We conclude from our results that heteroduplex PCR analysis of TCR gene rearrangements is a simple, rapid and cheap alternative to Southern blot analysis for detection of clonally rearranged TCR genes.

Entities:  

Mesh:

Year:  1997        PMID: 9447840     DOI: 10.1038/sj.leu.2400887

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  32 in total

1.  Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease.

Authors:  M Lima; J Almeida; A H Santos; M dos Anjos Teixeira; M C Alguero; M L Queirós; A Balanzategui; B Justiça; M Gonzalez; J F San Miguel; A Orfão
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system.

Authors:  D Gestri; L Baldacci; R Taiuti; E Galli; E Maggi; M P Piccinni; M Vergelli; L Massacesi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

Review 3.  The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies.

Authors:  Anna Gazzola; Claudia Mannu; Maura Rossi; Maria Antonella Laginestra; Maria Rosaria Sapienza; Fabio Fuligni; Maryam Etebari; Federica Melle; Elena Sabattini; Claudio Agostinelli; Francesco Bacci; Carlo Alberto Sagramoso Sacchetti; Stefano Aldo Pileri; Pier Paolo Piccaluga
Journal:  Ther Adv Hematol       Date:  2014-04

4.  Clonality and phenotyping of canine lymphomas before chemotherapy and during remission using polymerase chain reaction (PCR) on lymph node cytologic smears and peripheral blood.

Authors:  Dilini N Thilakaratne; Monique N Mayer; Valerie S MacDonald; Marion L Jackson; Brenda R Trask; Beverly A Kidney
Journal:  Can Vet J       Date:  2010-01       Impact factor: 1.008

5.  Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment.

Authors:  C Eckert; N Hagedorn; L Sramkova; G Mann; R Panzer-Grümayer; C Peters; J-P Bourquin; T Klingebiel; A Borkhardt; G Cario; J Alten; G Escherich; K Astrahantseff; K Seeger; G Henze; A von Stackelberg
Journal:  Leukemia       Date:  2015-03-09       Impact factor: 11.528

6.  A variant of SCID with specific immune responses and predominance of gamma delta T cells.

Authors:  Stephan Ehl; Klaus Schwarz; Anselm Enders; Ulrich Duffner; Ulrich Pannicke; Joachim Kühr; Françoise Mascart; Annette Schmitt-Graeff; Charlotte Niemeyer; Paul Fisch
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

7.  Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders.

Authors:  J Z Gong; S Zheng; R Chiarle; C De Wolf-Peeters; G Palestro; G Frizzera; G Inghirami
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

8.  Pitfalls in TCR gene clonality testing: teaching cases.

Authors:  Patricia J T A Groenen; Anton W Langerak; Jacques J M van Dongen; Johan H J M van Krieken
Journal:  J Hematop       Date:  2008-08-22       Impact factor: 0.196

Review 9.  Diagnostic role of tests for T cell receptor (TCR) genes.

Authors:  E Hodges; M T Krishna; C Pickard; J L Smith
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

10.  Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience.

Authors:  Małgorzata Dawidowska; Justyna Jółkowska; Tomasz Szczepański; Katarzyna Derwich; Jacek Wachowiak; Michał Witt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-12-01       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.